{"text": "amgn below avg volume daily appearances since 2010 275 close 5 days later avg 0 35 sd 6 69 worst 22 15 best 22 61 10 days later avg 0 31 sd 8 90 worst 28 70 best 29 70 30 days later avg 0 43 sd 15 26 worst 44 91 best 31 88"}
{"text": "amgn over reaction will be back up 2 77 change recently"}
{"text": "amgn reiterated by rbc capital neutral"}
{"text": "amgn azn the source phase 3 trial did not meet the primary endpoint of a statistically significant reduction in the daily oral corticosteroid dose without loss of asthma control with tezepelumab compared to placebo"}
{"text": "disclosure alert cytk cardiac therapy collaboration with amgn terminated"}
{"text": "short sale vol not short interest for amgn on 2020 12 22 is 44 gsk 48 gild 27 abt 40 biib 37"}
